France
Aptys Pharma, founded in 2002 and headquartered in France, is a pioneering CRDO specializing in the development of advanced pharmaceutical technologies and peptide delivery systems. The company's slogan, The formulation company, underscores its focus on innovative formulation development.
Aptys Pharma provides a comprehensive suite of services, including custom-made formulation development with both in vivo and in vitro assessments, semi-solid dosage forms for topical and transdermal delivery, injectable peptide depot formulations, and rigorous analytical development and validation processes. Adhering to ISO9001 standards and cGMP guidelines, the company ensures high-quality outputs through quality control and ICH stability testing.
The company operates primarily within the Biotechnology and Pharmaceutical industries. Its last noted investment, a Venture Round, was in March 2009, led by Sofimac Investment Managers, highlighting its potential for growth and innovation in this specialized sector.
